Giuseppe Boccuzzi
Turin, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Valproic Acid, a Histone Deacetylase Inhibitor, in Combination with Paclitaxel for Anaplastic Thyroid Cancer: Results of a Multicenter Randomized Controlled Phase II/III Trial.
Journal: International journal of endocrinology
Published: June 30, 2016
Radiofrequency ablation for thyroid nodules: which indications? The first Italian opinion statement.
Radiofrequency ablation for thyroid nodules: which indications? The first Italian opinion statement.
Journal: Journal of ultrasound
Published: February 13, 2015
Early surgery and survival of patients with anaplastic thyroid carcinoma: analysis of a case series referred to a single institution between 1999 and 2012.
Journal: Thyroid : official journal of the American Thyroid Association
Published: August 12, 2014
The pan-histone deacetylase inhibitor LBH589 (panobinostat) alters the invasive breast cancer cell phenotype.
Journal: International journal of oncology
Published: September 10, 2013
Advanced glycation end products promote hepatosteatosis by interfering with SCAP-SREBP pathway in fructose-drinking mice.
Journal: American journal of physiology. Gastrointestinal and liver physiology
Published: July 23, 2013
Histone deacetylase inhibition affects sodium iodide symporter expression and induces 131I cytotoxicity in anaplastic thyroid cancer cells.
Journal: Thyroid : official journal of the American Thyroid Association
Published: March 28, 2013
Histone deacetylase inhibition modulates E-cadherin expression and suppresses migration and invasion of anaplastic thyroid cancer cells.
Journal: The Journal of clinical endocrinology and metabolism
Published: May 08, 2012
Epigenetics modifications and therapeutic prospects in human thyroid cancer.
Journal: Frontiers in endocrinology
Published: December 09, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026